Related references
Note: Only part of the references are listed.Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume
Jessica Z. K. Caldwell et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Preclinical Comparison of the Amyloid-β Radioligands [11C]Pittsburgh compound B and [18F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis
Ann-Marie Waldron et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
Behrooz H. Yousefi et al.
EJNMMI RESEARCH (2015)
Cross-Sectional Comparison of Small Animal [F-18]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
Matthias Brendel et al.
PLOS ONE (2015)
Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function
Yi Su et al.
PLOS ONE (2015)
[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease
Shizuo Hatashita et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol
Anniina Snellman et al.
EJNMMI RESEARCH (2014)
PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains
Georg A. Becker et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography
Santiago Rojas et al.
NEUROBIOLOGY OF AGING (2013)
Evaluation of serotonin 5-HT1A receptors in rodent models using [18F]mefway PET
Neil Saigal et al.
SYNAPSE (2013)
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
Juha O. Rinne et al.
ACTA NEUROPATHOLOGICA (2012)
Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease
Anniina Snellman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease
Victor L. Villemagne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease
Sultan Darvesh et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
Andre Manook et al.
PLOS ONE (2012)
Image-derived input function for brain PET studies: many challenges and few opportunities
Paolo Zanotti-Fregonara et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Long-Term In Vivo Imaging of β-Amyloid Plaque Appearance and Growth in a Mouse Model of Cerebral β-Amyloidosis
Jasmin K. Hefendehl et al.
JOURNAL OF NEUROSCIENCE (2011)
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment
Edmond Teng et al.
NEUROBIOLOGY OF DISEASE (2011)
Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure
Jenna C. Carroll et al.
BRAIN RESEARCH (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Probing the Biology of Alzheimer's Disease in Mice
Karen H. Ashe et al.
NEURON (2010)
Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer's Disease
Claudia Kuntner et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease
J. Koivunen et al.
BRAIN (2008)
Development and evaluation of compounds for imaging of β-amyloid plaque by means of positron emission tomography
Gjermund Henriksen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography
Jun Maeda et al.
JOURNAL OF NEUROSCIENCE (2007)
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain
A. Guentert et al.
NEUROSCIENCE (2006)
Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde et al.
EMBO REPORTS (2006)
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
JC Price et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw
DY Hwang et al.
EXPERIMENTAL NEUROLOGY (2004)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
β-amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
CM Troy et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease
TC Dickson et al.
NEUROSCIENCE (2001)